XML 40 R30.htm IDEA: XBRL DOCUMENT v3.23.1
STOCK-BASED COMPENSATION PLANS (Tables)
3 Months Ended
Mar. 31, 2023
STOCK-BASED COMPENSATION PLANS  
Schedule of outstanding and exercisable number of options

    

Outstanding

    

Exercisable

Number of Options

Number of Options

(in thousands)

(in thousands)

Plan Category

 

  

 

  

2005 Stock Option Plan

 

211

211

2017 Stock Option Plan

 

356

355

Total

 

567

566

Schedule of stock-based compensation expenses recorded in the condensed consolidated statements of operations

The following summarizes stock-based compensation expenses recorded in the condensed consolidated statements of operations (in thousands):

For the Three Months Ended March 31, 

    

2023

    

2022

Cost of Revenue

$

8

$

15

Sales and marketing expense

 

61

 

59

General, and administrative

238

515

Total stock based compensation expense

$

307

$

589

Summary of stock option activity under all equity compensation plans

Weighted-

Weighted-

Average

Aggregate

Number of 

Average

Remaining

Intrinsic

Shares

Exercise

Contractual

Value

    

(in thousands)

    

Price

    

Term (Years)

    

(in thousands)

Outstanding at December 31, 2022

 

793

$

2.67

5.03

$

8,908

Granted

 

 

Forfeited

 

(206)

6.30

 

Exercised

(20)

6.07

Outstanding at March 31, 2023

 

567

$

1.24

3.32

$

6,104

Exercisable at March 31, 2023

 

566

$

1.22

3.31

$

6,099

Schedule of restricted stock award activity under all equity compensation plans

Number of

Weighted

Shares

 

Average

    

(in thousands)

    

Grant Date Fair Value

Granted but not vested at December 31, 2022

 

431

$

11.92

Granted

 

62

12.10

Forfeited

 

(3)

14.51

Vested

 

(46)

12.96

Granted but not vested at March 31, 2023

 

444

$

11.82